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SUMMARY.-The response to 5,10, 20 or 40 weekly paintings with DMBA of
the dorsal and vulval skin in intact and castrate rats is compared. Squamous
and basal celled tumours appear faster in the dorsal than the vulval region
with 5, 10 or 20 paintings, but at the same rate with 40 doses. The rate of
induction of epithelial tumours is optimal with 20 applications dorsally, but
increases with dose at the vulva. Progression ofmalignancy of squamous celled
tumours is greater and faster in the dorsal than in the vulval region. For basal
celled neoplasms of the vulva there is a peak va-lue in malignant conversion at
20 doses, but otherwise there is no consistent difference in the pattern at the two
sites. Castration reduces the incidence of basal celled tumours of the vulva in
ratspaintedweeklyforlife, but does not affecttheincidence ofepithelial tumours
of the skin. Sarcomas occur in 29% of rats in the dorsal region, but in only
04% at the vulva. Sarcomatous changes in the stroma of epitheliomas are
also more frequent in the dors'al skin. Local factors rather than variation in
individual sensitivity account for the differences withregion in the carcinogenic
response as shown by their persistence in rats treated simultaneously at both
sites.
An investigation of the dose-response pattern to the chemical carcinogen DMBA (9,10-dimethyl-1,2-benzanthracene) has revealed a striking difference in
the incidence of sarcomas induced in the dorsal skin (Cherry and Glucksmann,
1971) and in the vulva of rats (Glucksmann and Cherry,.,.1970). Depending on
number ofdoses given, females have up to 55% sarcomas in the dorsal skin, while
the highest incidence in the vulva is 2%. Differences in the response of the skin
to carcinogens with site have been reported for epithelial tumours in mice (Twort
and Twort, 1936) and for sarcomas in rats (Nothdurft, 1962; Ott, 1970). In the
dorsal skin sex differences in the liability to develop sarcomas have been demon-
strated and-at the vulva, but not at the dorsal skin, castration. influences the
development of basal celled tumours. Thus hormonal actions may play a role in
determining careinogenesis in addition to such environmental forces as exposure
to carcinogens. The present paper compares the effect of applying 5, 10, 20 or
40 weekly doses of DMBA to the dorsal skin or vulva of intact and castrate rats,
in inducing squamous or basal celled tumours and sarcoma's.
MATERIALS AND METHODS
The present analysis concerns the same groups of intact and cast-rate rats that
were included in previous investigations on the effect of DMBA dosage on the736 A. GLUCKSMANN AND C. P. CHERRY
induction of tumours of the vulva (Glucksmann and Cherry, 1.970) aiid of the
dorsal skin (Cherry and Glucksmann, 1971) and details of materials and methods
are given in these publications. The number of animals at risk can be seen in
Table 1.
RESULTS
Thehistogenesis ofskin as well as vulval tumours has been describedpreviously
and only a few remarks need to be added about the type of dermal changes
induced and their role in the formation of sarcomatous stroma or sarcomas (see
below).
Squamous celled tumours. The incidence of squamous celled tumours (carci-
nomas pluspapillomas) is ofthe same order in the dorsal skin and vulva except for
10 weekly applications which induce significantly more tumours in the dorsal skin
than in the vulva in intact and castrate animals (Fig. I and 2). Castration has no
TABLE I.-Incidence QfSarcomas
Dorsal skin Vulva
V
No. at, Sarcomas No. at Sarcomas No. at, Sarcomas No. at Sarcomas
DMBA risk % risk % risk % risk %
x 40 41 39 64 1-6 36 0
x 20 20 55 21 48 21 0 46 0
X10 21 29 22 18 21 0 22 0
x5 21 5 21 5 20 0 22 0
all 103 33 64 23 126 0-8 126 0
Y+_V 167 29 _252 0-4
effect. The progression to the mali nant stage is consistently greater hi the
dorsal skin than in the vulva where at the lowest dose levels it is promoted bv
castration.
The rate of tumour induction is faster in the skin than the vulva and reaches
an optimal level at 20 weekly doses, while at the vulva it increases with dose
(Fig. 3 and 4). At 40 doses the rate of tumour formation is equal at the two sites;
as many tumours are induced in the same time by 10 applications to the dorsal
skin as by 20 to the vulva in castrates, i.e. there is a factor of two which increases
considerably at 20 applications in intacts and castrates. If carcinomas alone are
considered (Fig. 5 and 6) the differences between vulva and dorsal skin are even
greater except for 40 doses in intacts where there is hardly any difference. No
carcinomas occur at the vulva with 5 and with 10 weekly applications of DMBA
in intacts though some appear in castrates.
Except for the greatest number ofpaintings there are thus marked differences
at the two sites in the rate of tumour induction and particularly in the rate of
progression to malignancy. At the dorsal skin 20 applications are optimal as
Tegards rate of tumour induction in intacts while at the vulva the rate of tumour
induction increases with dose. These differences may be due to DMBA being
distributed over a greater area of the dorsal skin than of the vulva because the
vulval region is smaller and exposure is due to contamination from the oozing
out of DMBA when the cervico-vaginal tract is painted. Obviously with 40
weekly doses this area effect-essentially due to number of epidermal cells atN,III
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FIG. 2.-Pereentage of squamous celled papillomas and carcinomas of the dorsal and vulval
skin in castrate rats induced by 5, 10, 20 or 40 weekly doses of DMBA.
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FIG. I.-Percentage of squamous ceBod papillomas and carcinomas of the dorsal and vulval
skin in intact rats induced by 5, 10, 20 or 40 weekly doses of DMBA.
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FIG. 3,4Cumulative incidence of squamous celled tumours (caminoma plus papillomas) in
the dorsal skin and vulva of intact rats given 5, 10, 20 or 40 weekly apphcations of DMBA.
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FIG. 4.--Cumulative incidence of squamous celled tumours (carcino phLs papiRo ) in
the dorsal skin and vulva of castrate rats given 5, 10, 20 or 40 weekly applications of DMBA.739
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FIG. 5.-Cumulative incidence of squamous celled carcinomas in the dorsal and vulval skin
of intact rats induced by 5, 10, 20 or 40 weekly paintings with DMBA.
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FIG. 6.-Cumulative incidence of squamous celled carcinomas in the dorsal and vulval skin
of castrate rats induced by 5, 10, 20 or 40 weekly paintings with DMBA.740 A. GLUCKSMANN AND C. P. CHERRY
risk-is overcome at the vulva, though the fact that this is not the maximal dose
for the dorsal skin may help in equalising the effect at the two sites.
Increasing the carcinogenic dosage affects the less sensitive animals (Cherry
and Glucksmann, 1971) by shortening the induction period which remains similar
for the most sensitive animals (Fig. 3-6), as indicated by the divergence between
the shortest and the longest period for tumours to appear. Only at the lowest
dose is the inductionperiod for even the most sensitive animalsprolonged. At all
dose levels the most sensitive animals differ less in the minimal induction period
for squamous celled tumours of the vulva and dorsal sUa than the less sensitive
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FIG. 7.-Percentage of basal celled papillomas and carcinomas of the dorsal and vulval skin
in intact rats induced by 5, 10, 20 or 40 weekly doses of DMBA.
rats. Whether individual sensitivity to the carcinogenic stimulation is7thesame
for the vulva and the dorsal skin, or whether in the same rat there-'are4local
differences in sensitivity is investigated in experiments in which the vulva as well
as the skin are painted at weekly intervals.
Basal celled tumours.-There are consistently, and in castrates, significantly
more basal celled tumours in the dorsal skin than in the vulva at au dose levels,
though with 40 applications the incidence in intacts at the two sites is almost
equal. At both locations only a few of the lesions progress to mahgnancy and
there is no consistent difference in the pattern ofprogression at the two sites, nor
does it appear to increase with dose except for a peak value in the vulva reached
with 20 doses (Fig. 7 and 8).CARCINOGENIC DOSAGE AND RAT SKIN TUMOUR INDUCTION 741
The rate of tumour induction is maximal at 20 doses for the dorsal skin of
intacts and for the vulva of castrates (Fig. 9 and 10). While in intacts the rate
at 40 doses in the vulvaequals that in the skin, at lower dose levels fewer tumours
are induced at the vulva and more slowly in all rats.
Sarcoma&-The greatest difference in the two sites is found in the incidence of
sarcomas (Table 1), with a single sarcoma occurring in the vulva of 252 rats at
risk as against 56 in the dorsal skin of 167 animals (29%). In the dorsal skin
sarcomas tend todevelop in the sarcomatous stromaofsquamouscelledcarcinomas,
as well as independently. In the vulva sarcomatous changes in the stroma of
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FIG. 8.-Percentage of basal celled Papillomas and carcinomas of the dorsal and vulval Skin
of castrate rats induced by 5, 10, 20 or 40 weekly doses of DMBA.
squamous celled carcinomas are exceedingly rare and in fact have been seen in
only one case. The stroma of carcinomas in the dorsal skin tends to be very
cellular, devoid of bundles of collagen fibres and to contain many enlarged cells
and numerous mitoses (Fig. II and 12), while in the vulva the collagen bundles
are preserved even close to infiltrating carcinomas, the dermal cells are ofnormal
size and mitoticfigures are rare (Fig. 13 and 14). The extent ofdermal changes is
also much greater than in the vulva. Thus even the initial dermal reactions at
the two sites appear to be different but in spite of this difference the epithelial
tumours are very similar and- at some dose levels their incidence and rate of
induction is the same, suggesting an independence of the development of carci-
nomas ofthe changes in the stroma.742 A. GLUCKSMANN AND C. P. CHERRY
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FIG. 9.-Cumulative incidence of basal celled neoplasms (carcinomas plus papillomas) in the
dorsal skin of the vulva of intact rats given 5, 10, 20 or 40 weekly applications of DMBA.
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FIG. 10.-Cumulative incidence of baml ceRed neoplasms (carcinomas plus papillomas) in
the dorsal skin and vulva of castrate rats given 5, 10, 20 or 40 weekly applications of DMBA.CARCINOGENIC DOSAGE AND RAT SKIN TUMOUR INDUCTION 743
Individual versus local sensitivity to carcinogenic stimulation.-To test whether
in individual rats the response to carcinogenic stimulation is equal forhomologous
tissues at different sites, a group of 21 intact animals has been given weekly
applications of DMBA for life to (a) the cervico-vaginal tract plus vulva and (b)
the dorsal skin. This treatmentresults in the induction of sarcomas in the cervico-
vaginal tract as well as three types of tumours (squamous and basal celled epi-
theliomas and sarcomas) each at the vulva and in the dorsal skin. Thus any rat
could have a maximum of seven distinct tumours at the treated sites. Of the
21 animals at risk two have six tumours, 11 have five neoplasms, four have four
lesions, three have three cancers and one only two. The combination of tumours
in individual rats is listed in Table 11. Basal celled tumours (papillomas plus
TABLE II.-Tumour Incidence in DorsalSkin, Vulva and Cervico-vaginal Tract
No. of rats
Squamous celled tumours
Carcinoma in skin and vulva 14
Carcinoma in skin, papilloma in vulva 4
Papilloma in skin, carcinoma in vulva 2
Papilloma in skin and vulva I
Basal celled tumours
Skin and vulva 16
Skin only 1
Vulva only 3
None I
Sarcomas
Skin and vulva 1
Skin and vagina 1
Vulva and vagina 0
Skin only 7
Vagina only 5
None 7
carcinomas) show the greatest agreement between vulva and dorsal skin, though
this result might not hold if castrate animals had been used There is very little
correlation between incidence of sarcomas at the three sites, while squamous
celled tumours show good agreement at the two sites, though carcinomas do less
so. The results of this experiment suggest that regional rather than over-all
individual sensitivity is responsible for the response to carcinogenic stimulation.
The rate of tumourdevelopment is the same for animals with six neoplasms as for
others with only three, four or five tumours.
DISCUSSION
The comparison of the response to DMBA painting of the dorsal skin and the
vulva is complicated by some dosage considerations, because it is difficult to
deliver the same amount of DMBA to the two sites and the size of the target area
is different. The dorsal skin is swabbed directly whereas the vulva is treated by the surplus of DMBA which oozes out of the vagina. The area of exposed skin
is far greater at the dorsal than the vulval region. Nevertheless with weekly paintings throughout life an equal proportion of rats produce epithelial tumours
at the same rate at the two sites and this fact indicates that at this level the
dosage is roughly equal. With a restricted number of weekly paintings (20, 10
and 5) the squamous celled tumours of the dorsal skin appear at a rate at least
twice as fast as those of the vulva. For basal celled tumours of the vulva the744 A. GLUCKSMANN AND C. P. CHERRY
incidence as well as the rate of induction is significantly less than in the dorsal
skin. For squamous celled tumours the ratio of carcinomas to papillomas is
consistently greater in the dorsal skin than in the vulva, whereas for basal celled
tumours there is no consistent difference in the progression to malignancy at the
two sites. While the ratio of incidence of squamous tumours for skin to vulva is
1-2 it is 1-7 for carcinomas in intact animals. The comparablefigures for castrates
are 1-4 and 1-8. For basal celled tumours the ratio at the two sites in intacts is
1-3 and in castrates 2-9 in favour of the dorsal skin, and confirms that castration
affects the carcinogenesis of these tumours at the vulva while hardly affecting
that of squamous celled epitheliomas. Castration does not influence carcino-
genesis in the dorsal skin.
The optimal dose phenomenon for the induction of squamous celled tumours
in the dorsal skin (Cherry and Glucksmann, 1971) is not observed at the vulva,
though it is seen in castrates as regards basal celled tumours.
The greatest difference at the two sites concerns the formation of sarcomas.
Allowing for the factor of 1-2 in the incidence of squamous celled epitheliomas in
intacts and of 1-4 in that for castrates, 30% ofintact and24% of castrate animals
should have sarcomas at the vulva if the response of the connective tissue at the
two sites were the same as that ofthe epidermis. In fact only 0-8% ofintact and
none of the castrate rats have sarcomas. Similarly sarcomatous changes in the
stroma ofepidermal tumours at the vulva are very rare, whileoccurringfrequently
in the dorsal skin. Thegreat difference in the carcinogenic response ofdermis and
epidermis at the two sites suggests that the neoplastic changes in the epithelium
are somewhat independent of the reaction of the connective tissue. There is
much less stroma around vulval epitheliomas than around tumours in the dorsal
skin and it is less cellular and devoid of abnormal fibroblastic cells. For the skin
a sex linked difference in favour of males has been found for the induction of
sarcomas but not for epithelial tumours (Cherry and Glucksmann, 1971). It thus
seems that site and sex have the greatest effect on the induction of sarcomas, the
least on that of squamous celled tumours and an intermediate one on basal celled
neoplasms.
That the differences in sensitivity to carcinogenic stimulation of homologous
tissues at different sites are due to local factors and not due to individual variations
in sensitivity is clearly shown in the experiment tabulated in Table II. For the
dorsal skin a similar independence in the production of sarcomas and carcinomas
can be demonstrated in intact and castrate females given five weekly treatments
with DMBA: one intact rat each had a carcinoma and one a sarcoma, while three
castrates have carcinomas only and another a sarcoma only. With 10 or more
paintings all rats have epithelial tumours, but only up to 55% sarcomas. The
EXPLANATION OF PLATES
FIG. 11-14 are microphotographs taken from the same intact rat 225 days after the first dose
of DMBA applied to the dorsal skin and the vulva.
FIG. 11 and 12.-Dorsal skinshowing the carcinoma and the extensivesurrounding very cellular
stroma which contains many divisions (m) andabnormallylarge and bizarre fibroblastic cells
(f). x 105 and x 320.
FIG. 13 and 14.-Vulva showing a squamous celled carcinoma surrounded by only sparse
fibrillar stroma and devoid of abnormal cells and mitoses. Dense fibrous dermal tissue (d)
persists close to the tumour. x 105 and x 320.BitiL SH JOURNAL OF CANCER Vol. XXV, No. 4
.-,. kA .. 16 -, N.
it,
.u,
-,. .
I - r
I, -,.?.9
AV
A
Glucksmann and Cherry.BRITISH JOURNAL OF CANCER Vol. XXV, No. 4
i
.;"W,
'2
I
I=
Id1
..v
ISWI
X:. I
.4
Glucksmann and Cherry.
4R
li-s- -, O'.CARCINOGENIC DOSAGE AND RAT SKIN TUMOUR INDUCTION 745
factors determining the local sensitivity to carcinogens are quite obscure and
hormonal actions as in the sex differences account foronly some ofthe differences.
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